| Metric | Value ($ M) | Q1 FY26 |
|---|---|---|
| Revenue | 520.26 | 12.2% |
| Total Income | 520.26 | 12.2% |
| Expenditure | 517.96 | 7.3% |
| PBT | — | |
| Net Profit | -5.02 | 159.1% |
| OPM | 0.44% | 5.26pp |
| NPM | -0.96% | 2.40pp |
| EPS | -0.20 | 158.8% |
Universal Corporation Reports Q1 FY27 Results with Revenue Down 12%
06 Aug 2026 · 6 Aug, 1:54 am
Summary
Universal Corporation reported a 12% decrease in revenue to $523.8 million for the first quarter of fiscal year 2027, driven by lower sales volumes and prices in its tobacco operations. The ingredients segment also saw a slight revenue decline of 3%. Gross profit margin contracted to 15.9% from 19.2% year-over-year, and the company reported a net loss of $5.0 million, or $(0.20) per diluted share, compared to a profit in the prior year. Management noted that the quarter's results reflected expected timing and market dynamics in the tobacco business, including oversupply conditions, and persistent consumer market headwinds in the ingredients business.
Key Highlights
- 1
Universal Corporation reported sales and other operating revenue of $523.8 million for the first quarter of fiscal year 2027, a decrease of 12% compared to the prior year.
- 2
Tobacco operations revenue decreased by 13% to $437.1 million, primarily due to lower sales volumes and prices.
- 3
Ingredients operations revenue was down slightly by 3% to $86.7 million, impacted by market headwinds.
- 4
Consolidated gross profit margin decreased to 15.9% from 19.2% in the prior year's quarter.
- 5
Net income attributable to Universal Corporation was a loss of $5.0 million, compared to a net income of $8.5 million in the prior year's quarter.
- 6
Diluted earnings per share were a loss of $(0.20), compared to $0.34 in the prior year's quarter.
- 7
Total debt decreased by $55.5 million to $1,183.9 million at June 30, 2026, compared to June 30, 2025.
Management Comments
Preston D. Wigner
We are starting fiscal year 2027 with confidence in the long-term strategic direction of our company. We are focused on creating sustainable value through disciplined execution across our businesses. In tobacco, we believe that our long-standing market expertise and measured approach position us well to navigate current oversupply conditions, make prudent buying decisions, and be a trusted, full-service partner to our customers. In ingredients, we are leveraging our platform growth investments and focusing on improving commercial execution, facility utilization, and financial and operational efficiencies. We expect certain of our improvement efforts to continue through our next fiscal year. Our first fiscal quarter results reflected the expected timing and market dynamics in our tobacco business, in comparison to our exceptional first quarter results in the prior fiscal year. Purchasing activity was slower as we and our customers evaluated green tobacco price trends amid oversupply conditions in flue-cured and burley markets and monitored potential weather impacts on next season’s crops. We are pleased with our current customer indications and commitments, and we expect customer demand to remain consistent with our fiscal year sales plan. In our ingredients business, revenue was down slightly from the prior year’s quarter, and results continued to be negatively affected by persistent consumer market headwinds, high fixed costs at our expanded Lancaster facility, and longer-than-anticipated product development cycles. We continued to implement our initiatives to strengthen the ingredients platform for long-term success, which include enhancements to leadership, systems, operational capabilities, and commercial execution. During the fiscal quarter, our liquidity position remained strong, and our debt levels were down due to reduced working capital usage, driven by tobacco crop purchase timing and lower green tobacco prices.
Informational and educational content only. Not investment advice.